广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
6期
757-759
,共3页
危重症%维生素D%APACHEⅡ%死亡率%预后%老年人
危重癥%維生素D%APACHEⅡ%死亡率%預後%老年人
위중증%유생소D%APACHEⅡ%사망솔%예후%노년인
Critically ill%Vitamin D%APACHEⅡ%Mortality%Prognosis%Elderly
目的:探讨老年危重症患者血清1,25羟-维生素D3[1,25(OH)2D3]水平与急性生理功能和慢性健康状态Ⅱ( APACHEⅡ)评分及预后的相关性,为临床治疗提供参考。方法老年危重症患者196例,检测入院第1天血清1,25(OH)2D3水平及住ICU第1个24 h的APACHEⅡ评分。根据APACHEⅡ评分分为3组:A组67例( APACHEⅡ评分≤15分),B组89例( APACHEⅡ评分16~25分),C组40例( APACHEⅡ评分>25分);根据追踪结果,分为存活组54例与死亡组142例。结果血清1,25(OH)2D3水平依次为A组>B组>C组(P <0.05)。器官衰竭数量依次为 A 组<B 组<C 组(P <0.05)。 A、B、C 组院内死亡率分别为2.99%(2/67)、30.34%(27/89)、62.50%(25/40),3组比较,差异有统计学意义(P<0.05)。院内死亡率依次为A组<B组<C组(P<0.05)。死亡组血清1,25(OH)2D3明显低于存活组(P<0.05),APACHEⅡ评分、器官衰竭数量明显大于存活组(P<0.05)。老年危重症患者血清1,25(OH)2D3水平与APACHEⅡ评分呈负相关关系(P<0.05),与院内死亡率呈正相关关系(P<0.05)。结论血清1,25(OH)2D3水平结合APACHEⅡ评分可作为评价老年危重症患者病情及预后的重要指标。
目的:探討老年危重癥患者血清1,25羥-維生素D3[1,25(OH)2D3]水平與急性生理功能和慢性健康狀態Ⅱ( APACHEⅡ)評分及預後的相關性,為臨床治療提供參攷。方法老年危重癥患者196例,檢測入院第1天血清1,25(OH)2D3水平及住ICU第1箇24 h的APACHEⅡ評分。根據APACHEⅡ評分分為3組:A組67例( APACHEⅡ評分≤15分),B組89例( APACHEⅡ評分16~25分),C組40例( APACHEⅡ評分>25分);根據追蹤結果,分為存活組54例與死亡組142例。結果血清1,25(OH)2D3水平依次為A組>B組>C組(P <0.05)。器官衰竭數量依次為 A 組<B 組<C 組(P <0.05)。 A、B、C 組院內死亡率分彆為2.99%(2/67)、30.34%(27/89)、62.50%(25/40),3組比較,差異有統計學意義(P<0.05)。院內死亡率依次為A組<B組<C組(P<0.05)。死亡組血清1,25(OH)2D3明顯低于存活組(P<0.05),APACHEⅡ評分、器官衰竭數量明顯大于存活組(P<0.05)。老年危重癥患者血清1,25(OH)2D3水平與APACHEⅡ評分呈負相關關繫(P<0.05),與院內死亡率呈正相關關繫(P<0.05)。結論血清1,25(OH)2D3水平結閤APACHEⅡ評分可作為評價老年危重癥患者病情及預後的重要指標。
목적:탐토노년위중증환자혈청1,25간-유생소D3[1,25(OH)2D3]수평여급성생리공능화만성건강상태Ⅱ( APACHEⅡ)평분급예후적상관성,위림상치료제공삼고。방법노년위중증환자196례,검측입원제1천혈청1,25(OH)2D3수평급주ICU제1개24 h적APACHEⅡ평분。근거APACHEⅡ평분분위3조:A조67례( APACHEⅡ평분≤15분),B조89례( APACHEⅡ평분16~25분),C조40례( APACHEⅡ평분>25분);근거추종결과,분위존활조54례여사망조142례。결과혈청1,25(OH)2D3수평의차위A조>B조>C조(P <0.05)。기관쇠갈수량의차위 A 조<B 조<C 조(P <0.05)。 A、B、C 조원내사망솔분별위2.99%(2/67)、30.34%(27/89)、62.50%(25/40),3조비교,차이유통계학의의(P<0.05)。원내사망솔의차위A조<B조<C조(P<0.05)。사망조혈청1,25(OH)2D3명현저우존활조(P<0.05),APACHEⅡ평분、기관쇠갈수량명현대우존활조(P<0.05)。노년위중증환자혈청1,25(OH)2D3수평여APACHEⅡ평분정부상관관계(P<0.05),여원내사망솔정정상관관계(P<0.05)。결론혈청1,25(OH)2D3수평결합APACHEⅡ평분가작위평개노년위중증환자병정급예후적중요지표。
Objective To investigate the correlation of serum 1,25 hydroxy-vitamin D3[1,25(OH)2D3]level with acute physiology and chronic health evaluationⅡ( APACHEⅡ) score and prognosis in critically ill elderly patients to provide guidance for clinical treatment .Methods One hundred and ninety-six elderly critically ill patients were tested for the serum 1,25(OH)2D3 level on the first day of admission and APACHEⅡscore in the first 24 hours in intensive medicine ( ICU) .The patients were divided into 3 groups according their APACHEⅡ scores,67 cases in group A(APACHEⅡscore≤15),89 cases in group B(APACHEⅡ score≥16 and ≤25) and 40 cases in group C ( APACHEⅡ score >25 ) .The patients were divided into survival group ( 54 cases ) and death group ( 142 cases ) according to the results of the treatment.Results The serum 1,25(OH)2D3 level was higher in group A in contrast with that in group B ,which was higher in group B in contrast with that in group C ( P<0 .05 ) .However ,the sequence of the numbers of organ failure was group A <group B<group C(P<0.05).The hospital mortalities in groups A,B, C were 2.99%(2/67),30.34%(27/89)and 62.50%(25/40),respectively,there was significant difference among three groups ( P<0 .05 ) .The hospital mortality was the highest in group C ,and was the lowest in group A ( P<0 .05 ) . The serum 1,25(OH)2D3 level in the death group was significantly lower than that in the survival group (P<0.05), while the APACHEⅡscore and numbers of organ failure were larger than those in the survival group ( P<0 .05 ) .The serum 1,25(OH)2D3 level negatively correlated with APACHEⅡ score(P <0.05),but positively correlated with hospital mortality(P<0.05) in critically ill elderly patients(P<0.05).Conclusion Serum 1,25(OH)2D3 level and APACHE Ⅱscore can be the important indicators for evaluating the severity and prognosis of critically ill elderly patients .